Search filters

List of works by Martin Smoragiewicz

A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study

scientific article published on 09 November 2019

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response

scientific article published on 30 October 2020

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.

scientific article

Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.

scientific article published on 15 December 2014

Design and conduct of early clinical studies of immunotherapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT)

scientific article published on 21 February 2020

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

scientific article published on 8 November 2017

Neutropenia and relative dose intensity on adjuvant FOLFOX chemotherapy are not associated with survival for resected colon cancer

scientific article published on December 2014

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell

scientific article published on 05 November 2015

Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?

scientific article

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

scientific article published on 12 February 2015

Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review

scientific article